The Aplastic Anemia and MDS International Foundation invites you to participate in our ONS Bridge satellite symposium, Emerging Therapies and Management Strategies for MDS and Myeloid Malignancies on Thursday September 17th at 5:00 pm.
MDS is challenging to diagnose, but the evolving genomic and immunologic landscape of MDS has led to notable improvements in the accuracy and timing of MDS diagnosis, prognosis, and identification of possible targets for therapeutic intervention. New therapies have been approved this year and several novel agents and combination therapies are in development, so it is important that nurses and nurse practitioners are aware of the treatment options available for this patient population.
Topics will include:
Case studies will be used to illustrate treatment decision-making and therapeutic challenges.
Our outstanding faculty has extensive inpatient and outpatient experience with MDS patients and will provide up-to-date information and practical guidance